Affiliate Disclosure
Effective September 2026
How this site makes money
Some links here can pay us a commission. When a provider is a paid partner, a click on its link may earn us money, at no extra cost to you.
Paid partners today: 33 of 422 providers compared. That count is generated from the same provider list the boards and reviews are built from, so it changes on the day the relationships change.
A commission is the only way this site earns, and no provider pays for a review, a score, a rank, or a place on a board.
There is no display advertising here, no sponsored article for sale, and no reader data sold to anyone. A commission on an outbound click is the whole of the revenue.
A commission is paid by the provider's own affiliate program. What you are charged is the provider's published price, the same figure you would meet by typing its address yourself.
Who publishes this, and what it is not
Compare Peptide is an independent comparison publication. It is not a pharmacy, a prescriber, a manufacturer, or a telehealth service.
It dispenses nothing, fills nothing, ships nothing, and takes no orders. A purchase is made on a provider's own site, under that provider's terms.
No company compared here owns any part of this site, and none has a seat in what gets published, including the companies that pay.
Placement can be commercial. The assessment is not.
Two different things happen on a comparison page, and telling them apart is the point of this disclosure.
Buttons, calls to action, and promotional slots are commercial surfaces. They exist to send qualified clicks to sellers, and a paid partner can appear in one.
The score, the written verdict, the pros and cons, and the compound evidence grade are not for sale. A partnership does not raise a score, delete a con, or change an evidence grade.
Where a commercial placement and an honest assessment pull against each other, the assessment stands and the placement moves.
That split is why the score is printed as plain text beside every ranked row. An order a reader can check against a number is an order that has to explain itself.
Paid partners are listed first, and the page says so
Ranked surfaces sort paid partners to the top, then by score, then by price. That is a commercial placement rule, and it is stated on the surfaces where it applies.
A row that got there that way carries a visible label reading Paid partner. The label is drawn from the same field the sort reads, so a row cannot be placed first and left unlabeled.
A paid row gets no louder button, no color of its own, and no badge that outranks an unpaid one. It gets a position and a label, and that is the whole of it.
The score printed in that row does not move with the label. A partner and a non-partner are graded against the same declared facts, by the same arithmetic.
Every provider link routes through /go/
Every outbound provider link is a same-origin redirect at /go/ followed by the provider slug. Paid or unpaid, the link takes the same hop.
For a paid partner, that hop carries this site's publisher id and the page context that earned the click, so the network can attribute it. For a provider that is not a partner, the hop carries no tracking at all and lands on the provider's own site.
A link that pays us and a link that pays us nothing look identical in the address bar. That is why the count above is computed rather than typed, and why a short disclosure sits beside every call to action.
On a partner's link, the identifiers added at the hop name this site, the offer, and the provider. They also record the page the click came from, the position in the list, the slot on the page, and which version of that slot was shown.
None of those identifiers is about you. They describe a page and a placement, which is what an attribution report is made of.
The hop is a redirect and nothing else. It sets no cookie of its own, and it builds no profile of the person following it.
The disclosure beside every button
A disclosure line sits immediately before every call to action, on that row, rather than once at the top of a page.
That line is generated from the provider's own partner field. It names the provider and says whether that particular provider is a paid partner.
So a reader never has to hold a list in their head while scanning a table. The sentence next to a button is about that button.
The panel that can appear on your way out
Clicking through to a provider that pays this site nothing can open one panel first, offering an alternative.
The alternative is a paid partner, and the panel says so inside itself, in the same words used beside every other call to action.
The panel is capped. It appears a small number of times in a visit at most, and never twice for the same company.
It never takes the destination away. Close it and the click goes exactly where you asked it to go.
It is a commercial interruption, and there is no honest way to describe it as anything else. It is disclosed here because it earns money from a click that would otherwise earn none.
The card in the margin
Review and research pages carry a card beside the reading column that promotes one provider.
The provider in that card is chosen from the provider list, prefers a paid partner, and is never the company the page is about.
The card carries its own disclosure before its own button. The button uses the same styling whether the provider pays us or not, so a paid slot cannot be made to shout.
What a commission never buys
A higher score, which comes from declared facts about what a provider publishes, and money is not one of them.
A softer review, since cons are written from what a provider does and does not publish, and they stay on the page after a deal is signed.
A better evidence grade, because grades belong to compounds rather than to sellers, and no seller can move one.
Silence about a warning letter, because letters are disclosed on the provider's review whether or not the provider pays us.
A place on a board. Nothing can be bought onto a board, and no fee takes a company off one.
A look at a page before it publishes. No provider reviews a draft, approves a sentence, or sees a score before a reader does.
A competitor's removal, or a quieter position for one.
What the evidence grade has to do with money
Nothing. An evidence grade belongs to a compound and never to the company selling it.
A compound's grade does not change depending on who is selling it, so there is no version of it a partnership could move.
The grade is rendered once near the top of a board rather than beside each row. Putting it in a row would imply it is a property of the vendor, which is the opposite of true.
Prices and offers
Prices here are dated snapshots of what a provider published on a stated day. They change without notice, and the provider's own page is the authority.
No figure on this site is an offer, a quote, or a promise of what you will be charged.
Every price carries the qualifier it was published under and the date it was read. A starting rate and an ongoing rate are different numbers, and dropping the qualifier turns a true figure into a false one.
A provider writing in to say its price is lower is a reason to read its published page again. It is not a price, and it does not move a date.
Nothing here is medical advice
Nothing on this site is medical advice, and nobody here is your clinician.
Whether a compound suits you is a question for a prescriber who knows your history, and this site cannot answer it.
These pages are built for shopping, and for arriving at an appointment with better questions. They are not built for settling what to take.
Provider names and marks
Provider names, logos, and compound brand names belong to their owners. They appear here to identify the company or the compound being compared, and for nothing else.
Their appearance implies no affiliation, endorsement, or sponsorship, whether or not the company is a paid partner. The trademarks page sets out the full position and how a rights holder raises a concern.
When the partner list changes
The count above, and the disclosure line beside each call to action, are generated from the provider list. Adding or ending a partnership updates both across the site the same day.
Anything that looks stale or wrong can be reported through the corrections page, including by the company being written about.
Nothing about a relationship is written into a page by hand. The count, the row labels, the sort order, and the sentence beside each button all read the same field on the same record.
That is also why no partner is named here and no fixed number is printed. A disclosure typed out by hand is one provider-list change away from being false, and it fails silently.
If something on this page looks wrong
Write to standards@comparepeptide.org with the address of the page and the sentence or figure at issue.
Anyone can report one, including a company writing about itself, and both are handled the same way. The corrections page sets out what happens next.